KI Academic Vice President for Doctoral Education since 2019
KI Chair of International Advisory Council
Professor of Immunotherapy in Neurological Diseases since 2013
Principal investigator for the Applied Immunology & Immunotherapy research group (Dept. Clinical Neurosciences) based at the Centre for Molecular Medicine
We are primarily interested in understanding the pathogenesis of incurable, chronic disease states of the Central Nervous System, including ALS, MS, Alzheimer's disease and glioma brain tumors.
HOW CAN WE TREAT OR CURE THE DISEASES? There is currently no cure for the diseases we study, and existing medications are only partly effective.
Our main interest is thus on developing new strategies to reduce or abrogate disease symptoms.
We focus on using the body’s own myeloid cells as a means of treating the same individual through ‘personalised cell therapy’ or by targeting these cells for immunomodulation.
Svensk presentation av Robert Harris' forskargrupp
Undergraduate teaching - M.Sc Biomedicine, Medical Degree - within the fields of myeloid cell biology, immunotherapy and autoimmunity
Postgradauate teaching - within the fields of myeloid cell biology, immunotherapy and autoimmunity
Postdoctoral/Professional development teaching - PhD supervisor training, Principle Investigator training, Leadership training
I teach extensively within these areas both at KI, nationally in Sweden and internationally.
1987 Portsmouth Polytechnic, BSc(Hons) Biology -Upper Second Class.
1991University College London, D.Phil.
1999 Associate Professor in Molecular Medicine, Karolinska Institutet.
2013 Professor in Immunotherapy of Neuroimmunologicaldiseases, Karolinska Institutet.
Akademiska priser och utmärkelser
Wellcome Trust Travel Fellow recipient1994-1996
British Council Visiting Professor Award 1996
KI pedagogy prize 2014